WILKES UNIVERSITY – NSG 533 (NSG533)
ADVANCED PHARMACOLOGY EXAM 2 –
QUESTIONS AND ANSWERS | 2026/2027 LATEST
UPDATE
SECTION 1: PAIN MANAGEMENT AND ANALGESIC PHARMACOTHERAPY
Questions 1–25
1. Which type of pain results primarily from activation of nociceptors by tissue injury or
inflammation?
A) Nociceptive pain
B) Neuropathic pain
C) Central sensitization pain
D) Psychogenic pain
Correct Answer: Nociceptive pain
Rationale: Nociceptive pain results from activation of peripheral nociceptors by actual or
threatened tissue injury. It commonly occurs with inflammation, trauma, surgery, or
musculoskeletal disorders. Neuropathic pain instead arises from dysfunction or injury of
neural tissue. Recognizing the mechanism helps clinicians select appropriate analgesic
classes and avoid relying exclusively on opioid therapy.
2. A pain syndrome caused by damage or dysfunction of peripheral or central nerves is
best classified as:
A) Visceral pain
B) Neuropathic pain
C) Somatic nociceptive pain
D) Inflammatory pain
Correct Answer: Neuropathic pain
Rationale: Neuropathic pain develops from abnormal processing caused by injury or
dysfunction of the nervous system. Examples include diabetic peripheral neuropathy and
postherpetic neuralgia. Because conventional analgesics may provide incomplete relief,
adjuvant agents such as gabapentinoids, selected antidepressants, or topical lidocaine are
often considered.
, 3. Which intervention represents a nonpharmacologic component of a multimodal
pain-management plan?
A) Increasing opioid dosage automatically
B) Combining two NSAIDs
C) Physical therapy and therapeutic exercise
D) Adding a second sedative
Correct Answer: Physical therapy and therapeutic exercise
Rationale: Multimodal pain management combines interventions that work through
different mechanisms. Physical therapy, exercise, heat or cold when appropriate, behavioral
strategies, and other nonpharmacologic measures can reduce pain and improve function.
Simply escalating medications can increase adverse effects without addressing functional
contributors to chronic pain.
4. The WHO analgesic ladder traditionally progresses from:
A) Opioids → NSAIDs → acetaminophen
B) Antidepressants → opioids → NSAIDs
C) Surgery → opioids → NSAIDs
D) Nonopioid analgesics → weak opioids or other escalation → stronger opioids when
appropriate
Correct Answer: Nonopioid analgesics → weak opioids or other escalation → stronger
opioids when appropriate
Rationale: The traditional WHO ladder emphasizes escalating analgesic intensity according
to pain severity and response. Nonopioid therapies are generally considered first, with
escalation to opioid therapy when indicated. Contemporary practice also emphasizes
multimodal treatment and individualized risk assessment rather than automatically
progressing through a rigid sequence.
5. Which pharmacologic action explains the principal analgesic and anti-inflammatory
effects of traditional NSAIDs?
A) Inhibition of cyclooxygenase enzymes and reduced prostaglandin synthesis
B) Direct activation of opioid receptors
C) Blockade of serotonin reuptake
D) Stimulation of GABA receptors
Correct Answer: Inhibition of cyclooxygenase enzymes and reduced prostaglandin
synthesis
,Rationale: NSAIDs inhibit cyclooxygenase enzymes, decreasing formation of prostaglandins
involved in pain, inflammation, and fever. COX-1 inhibition also contributes to
gastrointestinal and platelet-related adverse effects. COX-2-selective drugs were developed
to reduce some COX-1-mediated gastrointestinal effects, although cardiovascular and renal
risks remain important.
6. What is a major clinical concern when an NSAID is used chronically in an older adult?
A) Severe hypoglycemia
B) Gastrointestinal bleeding and renal injury
C) Permanent hearing loss in every patient
D) Vitamin C deficiency
Correct Answer: Gastrointestinal bleeding and renal injury
Rationale: NSAIDs can impair gastrointestinal mucosal protection and renal prostaglandin-
dependent blood flow. Older adults are particularly vulnerable to gastrointestinal bleeding,
kidney injury, fluid retention, and cardiovascular complications. Risk assessment should
consider age, renal function, cardiovascular disease, anticoagulant use, ulcer history, and the
intended duration of therapy.
7. Why does increasing an NSAID dose beyond an effective range often fail to produce
proportional additional analgesia?
A) NSAIDs become opioid antagonists
B) Higher doses eliminate prostaglandins permanently
C) NSAIDs can demonstrate a dose-related analgesic ceiling
D) NSAIDs stop entering the bloodstream
Correct Answer: NSAIDs can demonstrate a dose-related analgesic ceiling
Rationale: NSAIDs can reach a point at which additional dosing provides little additional
analgesic benefit while adverse-event risk continues to rise. This ceiling effect is clinically
important because excessive dosing does not necessarily improve pain control. Instead,
gastrointestinal, renal, cardiovascular, and other toxicities may become more likely.
8. Which statement best distinguishes acetaminophen from NSAIDs?
A) Acetaminophen is primarily an anti-inflammatory drug
B) Acetaminophen reliably inhibits platelet aggregation
C) Acetaminophen is contraindicated for all musculoskeletal pain
D) Acetaminophen provides analgesic and antipyretic effects but has little clinically useful
peripheral anti-inflammatory activity
, Correct Answer: Acetaminophen provides analgesic and antipyretic effects but has little
clinically useful peripheral anti-inflammatory activity
Rationale: Acetaminophen is useful for pain and fever but does not have the peripheral anti-
inflammatory activity characteristic of NSAIDs. It also does not provide the same antiplatelet
effect as aspirin. Its major dose-related concern is hepatotoxicity, particularly with excessive
total daily intake or significant risk factors.
9. When counseling about acetaminophen-containing combination products, which
instruction is most important?
A) Count acetaminophen from every medication source toward the total daily dose
B) Take multiple combination products together for stronger analgesia
C) Avoid reading OTC labels
D) Use alcohol to increase absorption
Correct Answer: Count acetaminophen from every medication source toward the total
daily dose
Rationale: Acetaminophen is present in many prescription and nonprescription combination
products. Patients can unintentionally exceed recommended amounts when they do not
recognize duplicate ingredients. Medication reconciliation and label review are therefore
essential, especially for people using opioid combinations, cold remedies, or other products
containing acetaminophen.
10. Which medication is an appropriate example of an adjuvant analgesic commonly
used for neuropathic pain?
A) Calcium carbonate
B) Gabapentin
C) Amoxicillin
D) Omeprazole
Correct Answer: Gabapentin
Rationale: Gabapentin is commonly used as an adjuvant for neuropathic pain. It modulates
neuronal signaling through binding to the alpha-2-delta subunit of voltage-gated calcium
channels. Other adjuvant options can include pregabalin, selected antidepressants, and
topical lidocaine depending on the condition and patient characteristics.
11. Duloxetine can be particularly useful in a patient with diabetic peripheral neuropathy
who also has depression because it:
A) Is a potent opioid agonist
B) Is an SNRI with activity against neuropathic pain and depression
ADVANCED PHARMACOLOGY EXAM 2 –
QUESTIONS AND ANSWERS | 2026/2027 LATEST
UPDATE
SECTION 1: PAIN MANAGEMENT AND ANALGESIC PHARMACOTHERAPY
Questions 1–25
1. Which type of pain results primarily from activation of nociceptors by tissue injury or
inflammation?
A) Nociceptive pain
B) Neuropathic pain
C) Central sensitization pain
D) Psychogenic pain
Correct Answer: Nociceptive pain
Rationale: Nociceptive pain results from activation of peripheral nociceptors by actual or
threatened tissue injury. It commonly occurs with inflammation, trauma, surgery, or
musculoskeletal disorders. Neuropathic pain instead arises from dysfunction or injury of
neural tissue. Recognizing the mechanism helps clinicians select appropriate analgesic
classes and avoid relying exclusively on opioid therapy.
2. A pain syndrome caused by damage or dysfunction of peripheral or central nerves is
best classified as:
A) Visceral pain
B) Neuropathic pain
C) Somatic nociceptive pain
D) Inflammatory pain
Correct Answer: Neuropathic pain
Rationale: Neuropathic pain develops from abnormal processing caused by injury or
dysfunction of the nervous system. Examples include diabetic peripheral neuropathy and
postherpetic neuralgia. Because conventional analgesics may provide incomplete relief,
adjuvant agents such as gabapentinoids, selected antidepressants, or topical lidocaine are
often considered.
, 3. Which intervention represents a nonpharmacologic component of a multimodal
pain-management plan?
A) Increasing opioid dosage automatically
B) Combining two NSAIDs
C) Physical therapy and therapeutic exercise
D) Adding a second sedative
Correct Answer: Physical therapy and therapeutic exercise
Rationale: Multimodal pain management combines interventions that work through
different mechanisms. Physical therapy, exercise, heat or cold when appropriate, behavioral
strategies, and other nonpharmacologic measures can reduce pain and improve function.
Simply escalating medications can increase adverse effects without addressing functional
contributors to chronic pain.
4. The WHO analgesic ladder traditionally progresses from:
A) Opioids → NSAIDs → acetaminophen
B) Antidepressants → opioids → NSAIDs
C) Surgery → opioids → NSAIDs
D) Nonopioid analgesics → weak opioids or other escalation → stronger opioids when
appropriate
Correct Answer: Nonopioid analgesics → weak opioids or other escalation → stronger
opioids when appropriate
Rationale: The traditional WHO ladder emphasizes escalating analgesic intensity according
to pain severity and response. Nonopioid therapies are generally considered first, with
escalation to opioid therapy when indicated. Contemporary practice also emphasizes
multimodal treatment and individualized risk assessment rather than automatically
progressing through a rigid sequence.
5. Which pharmacologic action explains the principal analgesic and anti-inflammatory
effects of traditional NSAIDs?
A) Inhibition of cyclooxygenase enzymes and reduced prostaglandin synthesis
B) Direct activation of opioid receptors
C) Blockade of serotonin reuptake
D) Stimulation of GABA receptors
Correct Answer: Inhibition of cyclooxygenase enzymes and reduced prostaglandin
synthesis
,Rationale: NSAIDs inhibit cyclooxygenase enzymes, decreasing formation of prostaglandins
involved in pain, inflammation, and fever. COX-1 inhibition also contributes to
gastrointestinal and platelet-related adverse effects. COX-2-selective drugs were developed
to reduce some COX-1-mediated gastrointestinal effects, although cardiovascular and renal
risks remain important.
6. What is a major clinical concern when an NSAID is used chronically in an older adult?
A) Severe hypoglycemia
B) Gastrointestinal bleeding and renal injury
C) Permanent hearing loss in every patient
D) Vitamin C deficiency
Correct Answer: Gastrointestinal bleeding and renal injury
Rationale: NSAIDs can impair gastrointestinal mucosal protection and renal prostaglandin-
dependent blood flow. Older adults are particularly vulnerable to gastrointestinal bleeding,
kidney injury, fluid retention, and cardiovascular complications. Risk assessment should
consider age, renal function, cardiovascular disease, anticoagulant use, ulcer history, and the
intended duration of therapy.
7. Why does increasing an NSAID dose beyond an effective range often fail to produce
proportional additional analgesia?
A) NSAIDs become opioid antagonists
B) Higher doses eliminate prostaglandins permanently
C) NSAIDs can demonstrate a dose-related analgesic ceiling
D) NSAIDs stop entering the bloodstream
Correct Answer: NSAIDs can demonstrate a dose-related analgesic ceiling
Rationale: NSAIDs can reach a point at which additional dosing provides little additional
analgesic benefit while adverse-event risk continues to rise. This ceiling effect is clinically
important because excessive dosing does not necessarily improve pain control. Instead,
gastrointestinal, renal, cardiovascular, and other toxicities may become more likely.
8. Which statement best distinguishes acetaminophen from NSAIDs?
A) Acetaminophen is primarily an anti-inflammatory drug
B) Acetaminophen reliably inhibits platelet aggregation
C) Acetaminophen is contraindicated for all musculoskeletal pain
D) Acetaminophen provides analgesic and antipyretic effects but has little clinically useful
peripheral anti-inflammatory activity
, Correct Answer: Acetaminophen provides analgesic and antipyretic effects but has little
clinically useful peripheral anti-inflammatory activity
Rationale: Acetaminophen is useful for pain and fever but does not have the peripheral anti-
inflammatory activity characteristic of NSAIDs. It also does not provide the same antiplatelet
effect as aspirin. Its major dose-related concern is hepatotoxicity, particularly with excessive
total daily intake or significant risk factors.
9. When counseling about acetaminophen-containing combination products, which
instruction is most important?
A) Count acetaminophen from every medication source toward the total daily dose
B) Take multiple combination products together for stronger analgesia
C) Avoid reading OTC labels
D) Use alcohol to increase absorption
Correct Answer: Count acetaminophen from every medication source toward the total
daily dose
Rationale: Acetaminophen is present in many prescription and nonprescription combination
products. Patients can unintentionally exceed recommended amounts when they do not
recognize duplicate ingredients. Medication reconciliation and label review are therefore
essential, especially for people using opioid combinations, cold remedies, or other products
containing acetaminophen.
10. Which medication is an appropriate example of an adjuvant analgesic commonly
used for neuropathic pain?
A) Calcium carbonate
B) Gabapentin
C) Amoxicillin
D) Omeprazole
Correct Answer: Gabapentin
Rationale: Gabapentin is commonly used as an adjuvant for neuropathic pain. It modulates
neuronal signaling through binding to the alpha-2-delta subunit of voltage-gated calcium
channels. Other adjuvant options can include pregabalin, selected antidepressants, and
topical lidocaine depending on the condition and patient characteristics.
11. Duloxetine can be particularly useful in a patient with diabetic peripheral neuropathy
who also has depression because it:
A) Is a potent opioid agonist
B) Is an SNRI with activity against neuropathic pain and depression
